Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Crepaldi

Showing results (111-120 of 288) with videos related to

Pageof 29
Sort By:
Pharmacological Research Communications|June 1, 1978
Effect of anorexiant drugs on growth hormone secretion in obese childrenA Baritussio, G Enzi, G Rigon, et al.
Atherosclerosis|June 1, 1996
Effect of withdrawal of pravastatin on biliary lipid composition in humansM Muraca, G Baggio, M T Vilei, et al.
Lancet (London, England)|February 8, 1992
Dexfenfluramine and neurotoxicityB Guy-Grand, M Apfelbaum, G Crepaldi, et al.
Journal of Endocrinological Investigation|September 13, 2007
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes managementG Crepaldi, M Carruba, M Comaschi, et al.
American Heart Journal|December 1, 1988
A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitusR Castrignano, A D'Angelo, T Pati, et al.
Diabetes & Metabolism|March 26, 2013
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatmentS Maggi, M Noale, A Pilotto, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1983
Insulin receptor on monocytes from patients with acromegaly and fasting hyperglycemiaM Muggeo, G A Saviolakis, V Businaro, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Pravastatin treatment in combined hyperlipidaemia. Effect on plasma lipoprotein levels and sizeS Zambon, A Cortella, G Sartore, et al.
Diabetes Care|December 1, 1994
Lipoprotein(a) levels in type II diabetic patients are not influenced by metabolic control or by microalbuminuriaS Zambon, G Baldo-Enzi, M Baiocchi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2009
A multicenter survey on profile of care for hip fracture: predictors of mortality and disabilityS Maggi, P Siviero, T Wetle, et al.
Pageof 29

Showing results (111-120 of 288) with videos related to

Sort By:
Pageof 29
Pharmacological Research Communications|June 1, 1978
Effect of anorexiant drugs on growth hormone secretion in obese childrenA Baritussio, G Enzi, G Rigon, et al.
Atherosclerosis|June 1, 1996
Effect of withdrawal of pravastatin on biliary lipid composition in humansM Muraca, G Baggio, M T Vilei, et al.
Lancet (London, England)|February 8, 1992
Dexfenfluramine and neurotoxicityB Guy-Grand, M Apfelbaum, G Crepaldi, et al.
Journal of Endocrinological Investigation|September 13, 2007
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes managementG Crepaldi, M Carruba, M Comaschi, et al.
American Heart Journal|December 1, 1988
A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitusR Castrignano, A D'Angelo, T Pati, et al.
Diabetes & Metabolism|March 26, 2013
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatmentS Maggi, M Noale, A Pilotto, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1983
Insulin receptor on monocytes from patients with acromegaly and fasting hyperglycemiaM Muggeo, G A Saviolakis, V Businaro, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Pravastatin treatment in combined hyperlipidaemia. Effect on plasma lipoprotein levels and sizeS Zambon, A Cortella, G Sartore, et al.
Diabetes Care|December 1, 1994
Lipoprotein(a) levels in type II diabetic patients are not influenced by metabolic control or by microalbuminuriaS Zambon, G Baldo-Enzi, M Baiocchi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2009
A multicenter survey on profile of care for hip fracture: predictors of mortality and disabilityS Maggi, P Siviero, T Wetle, et al.
Pageof 29